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I. Executive Summary 
In the modern world of healthcare, the role of the pharmacy intern is 
growing as hospitals look to decrease cost and increase care. The University of 
Kentucky Pharmacy Intern Program (UKPIP) employs pharmacy interns as 
pharmacist extenders to help complete the clinical task of medication reconciliation 
(med recs). The purpose of this study was to quantify the value of completing this 
task and determine whether it is cost effective to have interns or pharmacists in this 
role. 
The Institutional Review Board approved this study. UK’s electronic medical 
record database identified admission med recs completed by pharmacy interns and 
pharmacists in two different study periods. Each document was evaluated and a 
complexity scale was used to assign a value to each med rec utilizing a 
multiplication factor for those with higher numbers of home medications and those 
where additional research was required to obtain information, such as calling a 
pharmacy. Each complexity factor was multiplied by an hourly salary value for 
either an intern or a pharmacist to determine the cost of that med rec. 
Since the initiation of the pharmacy intern program, the number of daily med 
recs completed by pharmacists has significantly decreased and the number of med 
recs completed overall has significantly increased. Interns are completing med recs 
on more complex patients and are more likely to document their sources of 
information than pharmacists, a potential quality indicator. These results are 
skewed by the institution of a policy to complete a med rec within 24 hours of 
admission between the time of the control and study groups.  By comparing 
admission data, it was determined that the daily admissions were not significantly 
different between groups. Therefore, extrapolating the med recs that pharmacists 
would have potentially completed in the control group, with the same policy in place, 
leads to a cost savings of about 62% of funds previously allocated to med recs. 
At this time, the UKPIP is cost effective for the hospital. Interns have 
decreased the burden of work on pharmacists in a cost effective manner and there 
are indications that interns are completing quality work with value. Expanding the 
clinical role to similar tasks may be an appropriate next step for pharmacy interns. 
 II. Background: Problem Statement 
The Pharmacy Practice Model Initiative (PPMI) was developed by the 
American Society of Health-Systems Pharmacists (ASHP) to standardize and develop 
a practice model. This initiative addresses the major areas of pharmacy including 
roles for the pharmacist and technician as well as automation in delivering patient 
care. Unfortunately, it does not address the role of the student pharmacy intern. 
Student pharmacy interns can legally complete professional activities, such as 
patient counseling, and technical responsibilities, such as counting pills, with 
supervision.  
This broad scope of practice takes on different forms at hospital sites 
through intern programs. The main role published in current literature is to use 
interns as clinical extenders to complete initial patient interviews, called admission 
medication reconciliation (med recs). The process involves interviewing a patient to 
obtain information about the medications they take, clarifying this information with 
a second source and then discussing the information with the primary care team to 
resume necessary home medications.   
The main problem with this model is that it has not been financially justified. 
Intern programs are funded through hospitals based on traditional beliefs such as 
interns completing technical tasks and pharmacists’ obligation to train their 
successors. In this way, administrators have a sense that interns do not cost as much 
as pharmacists. However, there is no literature studying the financial impact of 
having interns complete med recs. 
Another issue with the role of the pharmacy intern is that the role changes at 
each practice site. The current literature shows that academic medical centers may 
benefit financially from med recs being completed by interns but smaller hospitals 
may need to rely on a different task for interns or a more diverse role.6 This 
Capstone will focus solely on med recs and then explore ideas for different sites. 
As the healthcare system evolves, the model of hospital pharmacy is expected 
to expand to help hospitals save money by providing optimal medication 
management. Since interns could complete some of the more time consuming and 
basic clinical tasks, which would free up the pharmacists’ time, their role could 
become more important. By showing that current models are either financially 
responsible or detrimental would be a benefit to bolstering existing programs, 
encouraging the development of new programs or refocusing efforts on more cost 
efficient endeavors.   
 The problem addressed by this Capstone is the financial implications of an 
intern program completing med recs. This was accomplished by conducting an 
extensive literature review of current intern program models and by utilizing the 
University of Kentucky Pharmacy Intern Program (UKPIP) as a case analysis. The 
goal of this Capstone is to provide an example of an effective, or ineffective, use of 
interns as clinical extenders and to determine whether that is financially feasible 
and in line with current literature. 
 
 
 
II. Background: Literature Review 
The variability of the job responsibilities of student pharmacy interns 
(interns) has been published throughout the history of pharmacy. Recently, the 
American Society of Health-Systems Pharmacists (ASHP) described the ideal 
practice model through their Pharmacy Practice Model Initiative (PPMI). The 
Consensus statement released after the initial Summit focuses on the optimal role of 
pharmacists and technicians. However, it does not exclusively mention the optimal 
role for students.1 
 Students are only noted in a few places in the Consensus statement. 
Specifically, interns are mentioned in 3 of the 147 consensus points. The first 
mention states that every pharmacy department should plan to have interns 
participate in drug therapy management services. The next mention is that training 
interns on the role of safety and quality in medication use is critical in implementing 
optimal practice models. Finally, the last mention is that it is necessary that training 
for interns be done on transitions of care.1 The major gap that this Consensus 
statement leaves is what types of activities or what types of training fulfill these 
goals and how to allocate money to complete training. Additional literature 
described below illustrates that hospitals are identifying med recs as an appropriate 
activity, but there is little data expanding on the financial impact of interns.  
  There are two types of interns, experiential and employed. The difference 
between these distinctions is that employed interns are paid for their time and work 
in addition to their curricular responsibilities, while experiential interns are free to 
the health system and are only completing those experiential responsibilities. In 
essence, every pharmacy student will complete required experiential internships 
but only some choose to have additional employed internships. Since experiential 
internships are more common, most research has focused on this role while 
minimal research has been published on the role of employed interns in a health 
system3-6. 
 In the state of Kentucky, internship credit can take the form of required 
academic experiential internships, employed internships or research related to the 
practice of pharmacy. Interns are allowed to complete both professional and 
practical pharmacy operations, such as filling medication orders or participating on 
patient care teams. First year pharmacy students must operate under direct 
supervision of a pharmacist preceptor, or a pharmacist who is registered to 
supervise interns by each state’s respective Board of Pharmacy. From then on, the 
intern can operate under general supervision of a preceptor.2 Again, this leaves a 
wide variety of roles for the intern to fill, whether employed or experiential.   
 Studies of experiential student contributions are mainly focused on 
discovering what types of interventions are made, perceptions of health care 
providers and contributions to recruitment. Two studies specifically addressed 
perceptions of health care providers who worked with interns. A study conducted at 
Mercer University Southern School of Pharmacy in Atlanta assessed the benefits of 
having pharmacy students on site at local hospitals. They achieved an 84% response 
rate and 79% of those hospitals reported that they felt the overall benefits of the 
educational affiliation outweighed any costs.3 Another study conducted in 
Massachusetts at four major medical centers surveyed health care providers who 
interacted with experiential students on a general medicine service. The majority of 
providers felt that student involvement was beneficial to patient care and that 
patient care recommendations were appropriate and accurate.4 
 Two further studies addressed types of interventions and contributions to 
recruitment. Delgado et al evaluated how the Cleveland Clinic in Florida utilizes 
their experiential students. Authors found that clinical interventions performed by 
students include med recs, disease state education, and discharge education. They 
also found that by having students, they were able to increase their clinical coverage 
to all patients in their hospital, in accordance with a PPMI goal, and to increase their 
residency recruitment opportunities5. Another case study evaluated students in a 
hospital in Ohio specifically tasked with obtaining admission medication data in an 
emergency department. While the service was successful, the hospital was unable to 
provide the service year round as the access to pharmacy students on experiential 
rotations was not consistent.6  
 These studies show that students have an effective role while completing 
clinical tasks in a hospital and that healthcare providers are open to their 
participation. The success of students in these studies indicates that employed 
interns could perform similarly. Bond et al further supported this implication in a 
study published in 2000.  
Bond identified clinical pharmacy services associated with lower cost of care 
including admission drug histories. Further, he found that as the number of clinical 
pharmacists employed increased, the overall cost of care decreased.7 This indicates 
that using pharmacy interns as clinical extenders may provide value for a health 
system. 
 A meta-analysis published in 2012 revealed 29 articles and 9 abstracts 
evaluating intern interventions in multiple care settings. Interns in inpatient 
settings provided an average number of recommendations per week of 3.6 per 
intern with acceptance rates of 39-98% from health care providers. The cost savings 
associated with these student recommendations ranged from $3,900 to $128,000 
per year or $500 to $6,000 per student per year. The literature review identified 
three articles showing that students are effective at completing medication 
histories.8 This publication indicates that there are cost savings associated with 
pharmacy students completing clinical interventions, further supporting the idea of 
the possibility of effective employed interns, and suggests that medication histories 
may be an appropriate clinical task for interns to complete. 
 In the PPMI Consensus statement, a key assumption noted is that pharmacy 
departments need to focus on becoming more efficient. One way the PPMI suggests 
to do so is to make med recs an integral part of optimal care. 1 The Joint Commission 
included med recs as part of its National Patient Safety Goals (NSPG) of 2014. 9 A 
survey of pharmacists participating in admission and discharge med recs at 
Vanderbilt University Hospital and Brigham Women’s Hospital reported that they 
felt med recs were the most important part of their job and also the most time 
consuming. They reported having an intermediary to triage initial med recs and 
identify patients that need additional pharmacist attention was essential to the 
pharmacists’ job.10   
 This trend in health care to emphasize the importance of med recs has led to 
multiple attempts at relieving the pharmacist burden of completing an 
overwhelming amount of clinical tasks. Some hospitals employ pharmacy 
technicians while others have seen a natural role for an intern. A case study 
completed by Hall et al reported a hospital utilizing both technicians and interns to 
complete med recs. The technicians and interns reviewed initial lists collected by 
nurses, reconciled them with the patient care team, and identified critical 
medications for pharmacists to review. Wages, other duties and cost avoidance or 
savings were not reported although pharmacists did report increased satisfaction 
with their work. 11  
 At this point in healthcare, literature suggests different sites have adopted a 
variety of intern programs attempting to decrease pharmacist burden. One such site 
includes Froedtert Hospital where interns are recruited to work evening and 
weekend shifts. The program is tiered so that less experienced interns are 
performing distributive tasks while more experienced interns are focused on 
clinical tasks including intravenous to oral medication switches, admission and 
discharge reconciliation, profile reviews, renal dosing and training new interns. 
Pharmacists traditionally completed these tasks. The study reports the intern 
program costs approximately $135,000 per year and is allocated 4 Full Time 
Equivalents.12 
 Other studies have also shown success with interns in tiered programs with 
salary increases per tier completing similar tasks as Froedtert interns.13,14 A survey 
conducted at hospitals in New York found that 47% of respondents reported 
employing interns and 73% reported interns performing at least one clinical activity. 
Trends were found towards higher clinical interventions in hospitals without 
minimum work requirements and hospitals with greater than four hundred beds. 
No differences were found between teaching and nonteaching hospitals.15  
 Unfortunately, the cost of employing an intern to complete the supported 
tasks described above has not been effectively addressed. Two studies attempted to 
quantify an intern’s financial impact but are not externally valid. The first was the 
previously mentioned study by Bond who found that the total cost of care in 
hospitals that provide admission drug histories decreased by $6,964,788 per year.7 
The second, a study by Campbell et al, identified 320 clinical interventions 
completed by 15 experiential interns in one year at a psychiatric hospital. It 
estimated the cost avoidance using a resource called Rx Medi-Trend and by 
averaging literature estimates. Both systems calculate cost avoidance based on the 
probability of avoiding an adverse drug reaction if the intervention was not 
completed.16 While both studies describe financial savings, they did not look directly 
at the cost of interventions but at potential cost savings using theoretical models.  
 The overall results of this literature review indicate that interns can 
successfully complete clinical interventions with health care provider acceptance, 
particularly med recs. There is limited data on the cost savings provided by having 
interns complete med recs versus the traditional model of pharmacists completing 
them. Therefore, the main research question addressed by this Capstone will be 
whether or not an intern completing med recs is more cost effective than a 
pharmacist performing the same task.  
III. Research Design 
Problem Statement:  
The role of the intern in the pharmacy practice model is not well defined. Multiple 
hospitals have instituted a hybrid pharmacy intern program where interns complete 
both clinical and technical tasks. The main clinical task identified through a 
literature search was med recs. A way to decide if this is cost effective outside of 
intangible benefits has not been established. 
At the University of Kentucky (UK), the UKPIP completes med recs in the evening 
and on weekends as clinical extenders- a task that was traditionally completed by 
pharmacists. UK also has a policy that states every patient admitted must have a 
documented attempted med rec within 24 hours. This site will be used as a case 
study. 
Research question: 
Is it cost effective for UKPIP interns to complete admission med recs instead of 
completion of this task by pharmacists?  
Objectives: 
1. Identify the number of med recs completed by pharmacy interns and 
pharmacists in the study periods 
2. Calculate interns’ and pharmacists’ compliance with policy 
3. Calculate the complexity of the med recs using the scale attached 
4. Calculate the cost associated with completing the med recs adjusted for 
complexity 
5. Compare the admission data for the two study periods  
Hypothesis: 
Interns complete more med recs, are more compliant with policy and cost less than 
pharmacists.  
Level of analysis: 
Pharmacists and interns at the University of Kentucky Chandler Medical Center that 
work in the evenings and on weekends.  
Sources of data: 
 A database report from Chandler Medical Center Pharmacy Department 
including pharmacist med recs completed from September 20, 2011- 
December 31, 2011 prior to the initiation of the UKPIP and after the 
requirement for med recs to be completed electronically. A database report 
for pharmacists from September 20, 2012-December 31, 2012 as well as 
pharmacy interns in the same time period including med recs completed.  
 A database developed by the Principle Investigator assessing individual med 
recs completed in the above report looking at the number of medications on 
each report, the source of information and whether or not it was completed 
in compliance with policy.  
 The IRB approved the research allowing access to patient charts for this 
analysis as well as the database reports per IRB Protocol 13-0899. 
 Daily census and new admission data from Chandler Medical Center’s 
financial office.  
 
Research design: 
Retrospective comparative financial analysis 
Data Analysis 
Objective 1: Identify the number of med recs completed by each group 
 An Excel command “Count” will be used to determine the number completed per 
day in each study group 
 Student t-test analyses will be run to determine if there has been a change in the 
number of med recs completed daily before and after the interns took 
responsibility for med recs 
Objective 2: Calculate compliance with policy of interns and pharmacists 
 In the database, each med rec will be assigned a value of 1, 2 or 3 in accordance 
with compliance with policy. A ‘1’ indicates it was completed within 24 hours, ‘2’ 
24-48 hours, and ‘3’ >48 hours. 
 Average compliance values will be calculated by dividing the number of med 
recs assigned ‘1’ by the total number of med recs per study group 
 The Chi-Square Goodness of Fit test will be used to evaluate each sample. 
Expected observations will be 100% for ‘1’ and 0% for ‘2’ and ‘3’.  
Objective 3: Calculate the complexity of the med recs  
 Each med rec will be assessed for number of drugs and source of information. 
They will be assigned a complexity factor as shown in the following tables.  
 
Table 1. Number of drugs 
Number of drugs Complexity factor 
< 5 0.5 
5 – 10 1 
11 – 15 1.5 
> 16 2 
 
Table 2. Source of information. 
Source of 
information 
Complexity factor 
Patient 0 
Family/caregiver 0 
Clinical record 0.25 
Pharmacy 0.5 
 
 The total complexity factor is equal to the sum of the complexity factor for the 
number of drugs and the source of information.  
 These factors were determined by assessing an initial 500 med recs showing the 
average med rec has between 5-10 medications.  This was assigned complexity 
factor of 1, or no change in cost besides the time associated with the interview, 
because it represents the average med rec. The most common sources of 
information in the pre-study group were patient and family or caregiver, which 
would add no additional time to an interview so no additional complexity. The 
other variables were given arbitrary increases in complexity that would cancel, 
as they are held constant across all groups. For example, it would take more time 
to reconcile more drugs and it takes more time to contact a pharmacy than to 
consult a clinical record so they received a higher complexity.  
 Student’s t-tests will be used to assess whether the daily mean complexity factor 
is the same between the 2011 pharmacist med recs and 2012 combined 
pharmacist and intern med recs as well as 2011 pharmacist med recs and 2012 
intern med recs alone.  
Objective 4: Calculate the cost associated with completing the med recs 
 Each med rec will be assigned a cost using the following formula: cost per med 
rec is equal to cost for complexity factor of ‘1’ multiplied by the total complexity 
factor for that med rec.  
 The cost for a complexity factor of ‘1’ was calculated using the table below. 
Table 3. Cost for a complexity factor of 1.  
 Average time for 1 
med rec 
Average hourly 
wage 
Cost for 
complexity factor 
of 1 
Intern 20 mins / 0.33 hr $13.18 $4.35 
Pharmacist 20 mins / 0.33 hr $46.34 $15.29 
Source: 2013-2014 University of Kentucky salaries 
 
 The average time for a med rec was determined based on personal experience 
and consultation with current interns and will cancel out as it is held constant 
across groups. The average hourly wage was calculated by averaging the wages 
of the interns and the wages of the clinical pharmacists who work similar shifts.  
The cost for a complexity factor of ‘1’ was calculated by multiplying the average 
hourly wage by the average time it takes to complete one med rec.  
 Final analysis will look at percentage of cost changes between groups rather 
than concrete numbers as some of the variables, such as average time, may not 
be accurate in terms of hard dollar changes but will not affect percent changes.  
 
Objective 5: Compare admission data for the two study periods 
 The policy to complete a med rec within 24 hours of a patient’s admission began 
early in 2012. This coincides with the interns starting to complete the bulk of 
admission med recs. 
 Daily admission data was obtained for both study periods. Student’s t-test will be 
used to determine if the number of admitted patients were similar in each time 
period. 
 The hypothesis is that the admission data will not be significantly different. 
Therefore, the number of admission med recs that would have been completed 
by pharmacists in 2011, if the policy had existed, will be obtained by 
extrapolating from the 2012 data. 
 
 
 
 
 
 
 
  
IV. Results 
Objective 1: Identify the number of med recs completed by each group 
The number of med recs were grouped by day since each study group was for the 
same amount of time. The total count is recorded in Table 3 and the results of the t-
test are recorded in Table 4. These results show that interns were completing 
significantly more med recs per day in 2012 (mean diff 13.4, p <0.05) and that 
pharmacists in 2012 were completing significantly fewer med recs per day when 
compared with the control group of med recs completed by pharmacists in 2011 
(mean diff -2.3, p < 0.05). This is important because the goal of the intern program 
was to decrease the number of med recs completed by pharmacists, which was 
accomplished despite a significantly lower amount of med recs completed by 
pharmacists in 2011, accounted for by a policy change discussed below.  
Table 4. Count of med recs per study group. 
Pharmacist 2011 388 
Intern 2012 1623 
Pharmacist 2012 149 
 
Table 5. Student’s t-tests for significance of med recs completed per day. 
 P-value Mean number of 
med recs per day  
95% 
Confidence 
Interval 
Difference 
Total 2012 <0.001 17.2 16.1-18.3 13.4 
Pharmacist 2011 3.8 3.2-4.4 
Pharmacist 2012  <0.001 1.4 98-1.9 -2.3 
Pharmacist 2011 3.8 3.2-4.4 
Intern 2012  <0.001 15.8 14.7-16.8 12.0 
Pharmacist 2011 3.8 3.2-4.4 
 
 
 
Objective 2: Calculate compliance with policy of interns and pharmacists 
Chi-square goodness of fit test was used to determine if compliance with policy 
differed significantly from expected compliance. Table 6 shows the results. The 
expected compliance with policy was 100%. As shown, the study groups in 2012 
were able to achieve this compliance as illustrated with small chi-square variables 
and p-values showing the results of the 2012 study groups are not significantly 
different from the expected results. It is important to note that the policy that states 
each patient must have a med rec completed within 24 hours of admission was 
instituted between the 2011 and 2012 study groups.  Therefore, the resultant high 
chi-square variable and p-value less than 0.05 associated with the pharmacist study 
group in 2011 is not surprising and represents a major limitation of this study. 
Table 6. Chi-square goodness of fit for policy compliance. 
 Frequencies of 
observation 
Chi-square 
variable 
p-value 
Pharmacist 2011 1 330 8.67 0.0131 
2 34 
3 24 
Intern 2012 1 1,576 0.85 0.6527 
2 32 
3 15 
Pharmacist 2012 1 143 0.24 0.8862 
2 5 
3 1 
 
Objective 3: Calculate the complexity of the med recs  
The complexity of each med rec was calculated using the scale described in the 
Research Design section above.  Figure 1a-1c represent the proportion of med recs 
assigned to each medication number category while Figure 2a-2c represent the 
proportion of sources utilized by each study group. As the graphics show, each 
group recorded similar numbers of medications in each med rec. However, the 
interns were much more likely to utilize the patient as their primary source and 
much more likely to document their source. Pharmacists in 2011 show 
undocumented sources almost 50% of the time and pharmacists in 2012 improve, 
but still show undocumented sources around 25% of the time. This is a quality 
indicator for the intern study group.  
  
  
  
Figure 1a. Pharmacists 
2011- Medications 
Reported 
<5
 5-10
 11-15
 >16
Figure 1b. Pharmacists 
2012- Medications 
Reported 
<5
 5-10
 11-15
 >16
 UTO
Figure 1c. Interns 2012- 
Medications Reported 
<5
 5-10
 11-15
 >16
 UTO
Figure 2a. Pharmacists 
2011-  
Primary Source Patient
 Family
 Clinical
Record
Pharmacy
 Unknown
Figure 2b. Pharmacists 
2012- Primary Source 
Patient
 Family
 Clinical
Record
Pharmacy
 Unknown
Figure 2c. Interns 2012- 
Primary Source 
Patient
 Family
 Clinical
Record
Pharmacy
 Unknown
The final complexity factor for each day was determined by averaging the 
complexity factor of all patients in each study group for each day. As shown in Table 
7, pharmacists in 2012 were completing med recs equally as complex as patients 
reached by pharmacists in 2011. However, it also shows interns in 2012 were 
completing significantly more complex patients than pharmacists in 2011. This 
could also be due to the interns more complete documentation of sources, which 
allow for a more accurate estimation of cost. The increased complexity is important 
because, per the developed scale, this means the interns in 2012 were completing 
more expensive med recs. This is preferred as interns are paid less per hour and it 
allows pharmacists to complete other clinical tasks that require a higher level of 
understanding and are more cost appropriate for pharmacists’ wages.  
Table 7. Student’s t-tests for significance of complexity factor (CF). 
 P-value Mean CF per day  95% 
Confidence 
Interval 
Difference 
Total 2012 0.85 0.86 0.79-0.93 -0.011 
Pharmacist 2011 0.87 0.78-0.96 
Intern 2012  <0.001 1.17 1.13-1.20 0.298 
Pharmacist 2011 0.87 0.78-0.96 
 
Objective 4: Calculate the cost associated with completing the med recs 
Table 8 describes the total cost of the med recs with multiple permutations. Sources 
were listed as “unk” or unknown if the pharmacist or intern did not document a 
source as defined in Table 2. The number of medications were listed as “UTO” or 
unable to obtain if the pharmacist or intern was not able to speak with the patient; 
For example, the patient was in surgery or intubated or the patient was unable to 
recall their medications. These incomplete med recs could still be included as the 
“unk” source med recs may still list medications and the “UTO” med recs may still 
list a source and could be included in the scale and associated with cost. These two 
limitations affect the complexity factor and therefore the overall cost so the cost was 
calculated including and excluding those med recs.  
In terms of overall cost, pharmacists in 2011 completed $6,215.39 worth of med 
recs with an average cost per med rec of $19.13, while pharmacists in 2012 were 
paid $2,656.64 for time associated with med recs at an average cost per med rec of 
$19.78. Meanwhile, interns were paid $8,220.41 to complete over 4 times as many 
med recs as pharmacists in 2011 with an average cost per med rec of only $6.10.   
Table 8. Total cost adjusted for complexity factor. 
 N Total cost Avg cost 
per med 
rec 
Avg cost 
without 
UTO/unk 
Percentage 
unk 
Percentage 
UTO 
Pharmacist 
2011 
388 $6,215.39 $15.98 $19.13 44.59% 0% 
Intern 
2012 
1623 $8,220.41 $5.07 $6.10 10.1% 3.36% 
Pharmacist 
2012 
149 $2,656.64 $17.83 $19.78 23.49% 2.65% 
 
An important conclusion to draw from this table is the percentage of unknown 
sources for each group as it is a potential quality indicator.  Documentation of 
sources allows for mistakes or misinformation to be tracked and represents 
appropriate patient care. Shown above, interns had the lowest percentage of 
undocumented sources at 10%, while pharmacists in 2011 had the highest at 
44.59%. Further, pharmacists in 2012 still had a rate of 24% unknown sources, 
indicating they have not changed their documentation habits.  
 
Objective 5: Compare admission data for the two study periods 
Since pharmacists were not required to complete med recs within 24 hours until the 
beginning of 2012, the control group is limited. Evaluating the daily admissions 
from each study period and using a t-test to determine if they are significantly 
different allows for the calculation of the number of med recs that potentially would 
have been completed in the 2011 group if the policy were in place. This can then be 
used to extrapolate a general cost difference. The results of the t-test are shown in 
Table 9 and new cost data in Table 10.  
Table 9.  Student’s t-tests for significance of daily admissions. 
 P-value Mean admits per 
day  
95% Confidence 
Interval 
Difference 
Admissions 2012 0.55 76.9 73.2-80.6 1.6 
Admissions 2011 75.3 71.5-79.1 
 
Table 10. Extrapolated Cost data 
 Current Cost Extrapolated Cost Percent 
Difference 
Pharmacist 2011 $6,215.39 $28,316.56 $17,439.51  
61.59% reduction 2012 $10,877.05 $10,877.05 
 
As shown above, the admission data is not significantly different, with mean admits 
per day being 76.9 and 75.3 people per day in 2012 and 2011 respectively (mean 
diff 1.6, p>0.05).  Therefore, the data from the total number of med recs completed 
in 2012 could be used to extrapolate an equivalent number of potential patients for 
pharmacists in 2011 using the total number of med recs performed in 2012 
multiplied by the average cost per med rec from 2011.  This assumption means that 
if pharmacists in 2011 had completed med recs on every patient within 24 hours of 
admission, the hospital would have paid them approximately $28,000. That is a 62% 
increase in cost from what was associated with med recs in 2012. 
  
V. Discussion 
Pharmacy interns are thought to bring value to a hospital for a lot of different 
reasons. This Capstone evaluated whether pharmacy interns can potentially save 
hospitals money by completing clinical tasks traditionally completed by pharmacists. 
Results shown above are generally positive for interns and show potential 
cost reductions. However, there are a few limitations to be noted. 
There are a multitude of variables that affect the med recs completed by the 
UKPIP and pharmacists. First, the institution of new policy and availability of 
electronic medical records that make it easier to document admission med recs. The 
next variable in med recs is daily census data and number of new admissions. 
Another variable is the trust bestowed upon the pharmacist or intern to allow them 
to complete med recs.  This increases as a service is established. Finally, the 
complexity of the patient population is variable and affects the time taken to 
complete a med rec and ultimately the cost. 
This study attempted to control for these things by utilizing study periods 
after establishment of electronic medical records. Unfortunately, it was unable to 
standardize to policy, but with equal daily admissions, conclusions can still be made 
by extrapolating data. The study period is at a time when the UKPIP was already 
established and entrusted with full responsibility for med recs during their shifts. 
Daily census and admission data were taken into account during analysis to 
standardize data. Finally, the variability of the patient population was considered 
random per service covered by a pharmacist or intern (for example, surgery 
patients) but the complexity overall was analyzed using number of medications and 
source of information to see if interns were entrusted with an equally complex 
patient population. Of note, interns and pharmacists in this study worked the same 
shifts and served the same patient population.  
The external validity of this study presents multiple problems. Since it is a 
singular case study, it is difficult to apply results to locations other than the 
University of Kentucky. However, the majority of hybrid intern programs currently 
exist at tertiary academic medical centers with interns completing med recs so the 
results will probably be externally valid at those locations. There will not be 
external validity at small, community hospitals or places without electronic medical 
records. The general assumptions made about interns in practice models and 
potential roles for them are externally valid because the concepts can be adopted 
with variations for actual tasks completed based on the needs of different practice 
sites. The main objective for external validity was to show there is a cost effective 
role for interns and each site needs to identify what task completion will show 
similar cost effectiveness for them.  
This study is unique in it’s design as it attempted to identify the specific cost 
associated with completing one specific clinical task. However, this makes it difficult 
to assess since there are not preceding studies to compare. The positive results 
presented should be interpreted carefully, keeping in mind the maturity of the 
financial calculations applied.  
 
 
  
VI. Conclusions 
Overall, this study shows that completing med recs is an appropriate task for 
an intern program at a tertiary academic medical center. Interns in the UKPIP were 
able to perform the bulk of med recs at the hospital, document appropriately and 
reduce the workload for pharmacists.  
These results show that interns are completing quality interventions by 
traditional standards such as documenting work and thoroughly investigating 
patient profiles. Pharmacists are completing fewer med recs, which was the goal of 
the intern program. Interns are reaching patients who are more complex and 
require a more time-consuming interview, as well as completing further 
investigation with pharmacies and clinical records to verify the patients’ medication 
profiles. This means that they are freeing up time for pharmacists to complete other 
tasks to contribute to patient care. 
The financial implications of this study are positive. Using the scale 
developed by the Principle Investigator, the interns present a possible cost 
reduction of 60% of cost associated with one clinical task. If other clinical tasks 
prove equally as beneficial, programs could potentially pay for themselves and then 
some.  
However, future research can be completed to improve on this study. First, a 
prospective study to validate the scale developed here would be beneficial. Next, 
evaluating quality indicators to determine if interns’ work is equivalent to 
pharmacists’ work. Finally, a more complete cost analysis could be completed 
including all clinical and technical tasks completed by the intern program as well as 
the cost to train and educate interns.  
In conclusion, this retrospective comparative analysis is in line with current 
literature as it supports the completion of med recs by interns. Further, it illustrates 
concretely, for the first time, that interns are financially beneficial as well. Overall, it 
supports the institution of interns as clinical extenders for hospital pharmacists.  
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